Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Gut Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1508473

This article is part of the Research Topic The Mechanism in Gut Microbiota of Diabetes and Endocrine Complications: Preventive and Therapeutic Target View all 10 articles

Animal studies on the modulation of differential efficacy of polyethylene glycol loxenatide by intestinal flora

Provisionally accepted
Wenjiao Dang Wenjiao Dang Wenjiao Dang Wenjiao Dang Wang Yurou Wang Wang Yurou Wang Xie Jiaqi Xie Xie Jiaqi Xie He Yan He He Yan He Ji Hongfang Ji Ji Hongfang Ji Chen Min Chen Chen Min Chen Guo Jianjin Guo Guo Jianjin Guo *
  • Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, China

The final, formatted version of the article will be published soon.

    Background:Gut microbiota has demonstrated an increasingly important role in the onset and development of type 2 diabetes mellitus (T2DM), Further investigations have revealed the interactions between drugs and the gut microbiome. However, there are still gaps in research regarding the potential interactions between the gut microbiota and GLP-1 and their therapeutic response in people with T2DM. In addition, Fecal microbiota transplantation (FMT) has become a promising strategy for patients with T2DM.

    Keywords: type 2 diabetes, intestinal flora, GLP-1 receptor agonists, polyethylene glycol exenatide, fecal microbiota transplantation, 16S rDNA

    Received: 09 Oct 2024; Accepted: 24 Mar 2025.

    Copyright: © 2025 Wenjiao Dang, Wang, Xie, He, Ji, Chen and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guo Jianjin Guo, Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more